Absci Corporation (ABSI)
NASDAQ: ABSI · IEX Real-Time Price · USD
3.970
-0.140 (-3.41%)
At close: Jul 19, 2024, 4:00 PM
4.000
+0.030 (0.76%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
Absci Revenue
Absci had revenue of $5.35M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $898.00K. In the year 2023, Absci had annual revenue of $5.72M.
Revenue (ttm)
$5.35M
Revenue Growth
-13.72%
P/S Ratio
83.96
Revenue / Employee
$34,497
Employees
155
Market Cap
448.94M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
Dec 31, 2019 | 2.06M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bioventus | 522.74M |
Pacific Biosciences of California | 200.43M |
Voyager Therapeutics | 119.04M |
EyePoint Pharmaceuticals | 50.02M |
MaxCyte | 44.05M |
Taysha Gene Therapies | 14.16M |
Nano-X Imaging | 10.01M |
Altimmune | 410.00K |
ABSI News
- 12 days ago - Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024 - GlobeNewsWire
- 18 days ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 4 months ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results - GlobeNewsWire
- 5 months ago - Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 months ago - Absci Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 5 months ago - Absci Announces Proposed Public Offering of Common Stock - GlobeNewsWire